Autoimmune Comorbidities Are Associated with Brain Injury in Multiple Sclerosis

The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review

(2015) Ruth Ann Marrie et al.   Multiple Sclerosis Journal

The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review

(2015) Ruth Ann Marrie et al.   Multiple Sclerosis Journal

Vascular comorbidities in the onset and progression of multiple sclerosis

(2014) Prudence Tettey et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: A systematic review

(2014) Ruth Ann Marrie et al.   Multiple Sclerosis Journal

Psychiatric comorbidity in multiple sclerosis: It’s not the genes

(2014) Ruth Ann Marrie   Multiple Sclerosis Journal

A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis

(2014) Ruth Ann Marrie et al.   Multiple Sclerosis Journal

A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis

(2014) Ruth Ann Marrie et al.   Multiple Sclerosis Journal

A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis

(2014) Ruth Ann Marrie et al.   Multiple Sclerosis Journal

Alemtuzumab-Related Thyroid Dysfunction in a Phase 2 Trial of Patients With Relapsing-Remitting Multiple Sclerosis

(2013) Gilbert H. Daniels et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Lipid profiles are associated with lesion formation over 24 months in interferon-β treated patients following the first demyelinating event

(2013) Bianca Weinstock-Guttman et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia

(2012) Ruth Ann Marrie et al.   Multiple Sclerosis Journal

Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

(2012) Robert J. Fox et al.   NEW ENGLAND JOURNAL OF MEDICINE

Multiple sclerosis: more pieces of the immunological puzzle

(2011) Ralf Gold et al.   LANCET NEUROLOGY

Abnormal subcortical deep-gray matter susceptibility-weighted imaging filtered phase measurements in patients with multiple sclerosis

(2011) Robert Zivadinov et al.   NEUROIMAGE

Multiple sclerosis: risk factors, prodromes, and potential causal pathways

(2010) Sreeram V Ramagopalan et al.   LANCET NEUROLOGY

Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis

(2010) R. A. Marrie et al.   NEUROLOGY

Imaging outcomes for neuroprotection and repair in multiple sclerosis trials

(2009) Frederik Barkhof et al.   Nature Reviews Neurology

Smoking is associated with increased lesion volumes and brain atrophy in multiple sclerosis

(2009) R. Zivadinov et al.   NEUROLOGY